Advanced Unresectable Gastric Cancer
1 clinical trials · Condition
◉ Watch Advanced Unresectable Gastric Cancer
| Record | Firm | Date |
|---|---|---|
| Sorafenib, Docetaxel, and Cisplatin in Treating Patients With Metastatic or Advanced Gastric or Gastroesophageal Junction Cancer (NCT00253370) | National Cancer Institute (NCI) | 2005-10-01 |
Track Advanced Unresectable Gastric Cancer automatically
Every clearance here is in the API, with alerts when new ones post.